Overview
- Editors:
-
-
H.-J. Biersack
-
Klinik und Poliklinik für Nuklearmedizin, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany
-
F. Grünwald
-
Klinik für Nuklearmedizin, Universität Frankfurt, Frankfurt am Main, Germany
- Complete coverage of all available diagnostic tools
- Includes new therapeutic approaches such as high-dose radioiodine therapy and redifferentiation therapy
- Features special section on medullary thyroid cancer
- Includes supplementary material: sn.pub/extras
Access this book
Other ways to access
Table of contents (20 chapters)
-
Front Matter
Pages I-XXIII
-
Basics
-
-
-
- M.R. Carlisle, I.R. McDougall
Pages 57-70
-
-
-
Differentiated Thyroid Cancer
-
- M. Dietlein, D. Moka, H. Schicha
Pages 95-126
-
- L.S. Freudenberg, A. Bockisch, W. Jentzen
Pages 127-138
-
- M. Biermann, M.K. Pixberg, A. Schuck, N. Willich, A. Heinecke, O. Schober
Pages 139-161
-
-
-
-
- B. Shapiro, J. Freitas, M. Gross
Pages 199-219
-
-
-
-
- C. Reiners, J. Biko, E.P. Demidchik, V. Drozd
Pages 283-293
-
About this book
One of the main reasons for publishing this second edition of “T- roid Cancer” is the fact that the first edition has sold out. Furth- more, during the 4 years following the publication of the first edition in 2001, some progress, mainly in the basic sciences (molecular biology), has been made. The most prominent change in the clinical sciences has been the new classification of thyroid cancer, especially with relation to T1–T3 tumors. Now, tumors with a diameter of up to 2 cm are still classified T1. This new UICC classification (6th edition) follows the classification of the American Society of Pathology. These changes require a modification of the old guidelines. According to the Hedinger classification (1988) tumors with a diameter below 1 cm were classified as “papillary microcarcinoma of the thyroid”. Only in those tumors was total or nearly total thyroidectomy deemed unn- essary and I-131 therapy not a prerequisite for treatment. The majority of the chapters has been updated including references to many new publications. Two new chapters, on I-124 PET and - simetry, have been added. We strongly feel that this second edition of “Thyroid Cancer” is again a state-of-the-art overview of the diagnosis and treatment of thyroid cancer. Bonn, Frankfurt am Main H. -J. Biersack, F. Grünwald Preface to the First Edition Thyroid cancer was first described at the end of the eighteenth c- tury.
Reviews
RAD Magazine, July, 2006: "This latest edition is packed full of facts, updated references and illustrations ... If your everyday care involves thyroid cancer patients, this book is a must."
Editors and Affiliations
-
Klinik und Poliklinik für Nuklearmedizin, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany
H.-J. Biersack
-
Klinik für Nuklearmedizin, Universität Frankfurt, Frankfurt am Main, Germany
F. Grünwald
